de Silva Kumudika, Plain Karren, Purdie Auriol, Begg Douglas, Whittington Richard
Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Australia.
Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Australia.
Vet Immunol Immunopathol. 2018 Jan;195:56-64. doi: 10.1016/j.vetimm.2017.11.008. Epub 2017 Nov 24.
Paratuberculosis is an insidious, chronic disease of ruminants that has significant animal welfare implications and reduces on-farm profitability globally. Not all animals exposed to the causative pathogen, Mycobacterium avium subspecies paratuberculosis (MAP), succumb to disease and this unique, long-term trial was designed to track animals that were resilient. The advantages of understanding immune protection include the management option to retain resilient individuals in a herd/flock and the potential for deliberate manipulation of the host immune response using novel vaccines. Twenty sheep experimentally exposed to MAP and 10 controls were monitored for 2.5 years during which the condition progressed, resembling natural disease development. Cellular and humoral immune parameters and faecal MAP shedding were examined regularly and disease outcomes were classified at necropsy, based on the presence of viable MAP and histopathological lesions in intestinal tissues, either at the termination of the trial or when animals were culled due to weight loss. There were distinct characteristics, such as an early strong IFNγ response, that differentiated resilient sheep from susceptible individuals prior to the onset of clinical disease. Faecal MAP shedding and serum antibody level, commonly used to diagnose disease, were more ambiguous. The former was transient in the majority of resilient animals and therefore should not be used for diagnosis of MAP infection in younger animals. Remarkably, the serum antibody level in some resilient animals was higher than the usual positive-negative cut-off for disease diagnosis at multiple samplings throughout the trial. Consequently the antibody response in resistance to paratuberculosis requires further investigation.
副结核病是反刍动物的一种隐匿性慢性疾病,对动物福利有重大影响,并降低了全球农场的盈利能力。并非所有接触致病病原体——副结核分枝杆菌(MAP)的动物都会发病,这项独特的长期试验旨在追踪具有抵抗力的动物。了解免疫保护的好处包括在畜群/禽群中保留有抵抗力个体的管理选择,以及使用新型疫苗有意操纵宿主免疫反应的可能性。对20只经实验接触MAP的绵羊和10只对照绵羊进行了2.5年的监测,在此期间病情不断发展,类似于自然疾病的发展过程。定期检查细胞和体液免疫参数以及粪便MAP脱落情况,并在试验结束时或动物因体重减轻被扑杀时,根据肠道组织中活MAP的存在情况和组织病理学病变,在尸检时对疾病结果进行分类。在临床疾病发作之前,有一些明显的特征,如早期强烈的IFNγ反应,可将有抵抗力的绵羊与易感个体区分开来。通常用于诊断疾病的粪便MAP脱落和血清抗体水平则更不明确。前者在大多数有抵抗力的动物中是短暂的,因此不应将其用于诊断幼龄动物的MAP感染。值得注意的是,在整个试验的多次采样中,一些有抵抗力动物的血清抗体水平高于疾病诊断通常的阳性-阴性临界值。因此,抵抗副结核病的抗体反应需要进一步研究。